March 4, 2009 - Physicians will be able to move away from pure surgical approaches and utilize less invasive techniques for the treatment of structural heart disease with the help of cardiovascular ultrasound technology, according to a new guideline document in the March issue of the Journal of the American Society of Echocardiography (JASE).

March 4, 2009 - Cambridge Heart Inc. yesterday said five articles were recently published supporting the use of Microvolt T Wave Alternans (MTWA) testing in a supplement to the March issue of the Heart Rhythm Journal.

Featured in the supplement is a comprehensive meta-analysis of 6,000 patients confirming the value of MTWA as a non-invasive marker of risk for sudden cardiac arrest (SCA).

March 4, 2009 –– Since the implementation of Medsphere’s OpenVista electronic health record (EHR), Midland Memorial Hospital (MMH) has realized a host of improved clinical results, including fewer patient deaths and medical errors and decreased infection rates, an independent case study confirms.

March 4, 2009 - W. L. Gore & Associates has earned a spot on Fast Company magazine’s 2009 “Fast 50” list of the world’s most innovative companies, partly for its development of the GORE HELEX Septal Occluder.

Gore is ranked number 30 and appears in the magazine’s March issue.

March 4, 2009 – Customer ratings for GE Healthcare Devices Services, which provides service for telemetry, patient and holter monitors, in addition to cardiac stress, cardiology management and electrocardiograph systems, according to a 2008 IMV ServiceTrak and Q4 2008 MD Buyline reports.

March 4, 2009 – INFINITT will present Xelis, a new line of clinical imaging tools using volume rendering and other post-processing techniques designed for improved visualization, treatment planning and workflow, which is expecting CE approval in March 2009.

March 3, 2009 – NovaRad has released a new system for cardiovascular labs, hospitals and other sites requiring both a PACS and a cardiovascular reporting system (CRS).

March 3, 2009 - Boston Scientific Corp. today said it launched its TAXUS Liberté Paclitaxel-Eluting Coronary Stent System in Japan.

The product was approved on Jan. 28 by the Ministry of Health, Labor and Welfare, and reimbursement was granted yesterday by the National Health Insurance System.

March 3, 2009 – Researchers in The Netherlands say contrast dose in the cath lab can be significantly reduced or eliminated by using a combination of multislice CT angiography, magnetic navigation, fractional flow reserve (FFR) measurement catheters, and IVUS.

March 3, 2009 - A recently published article in the Journal of Heart and Lung Transplantation (JHLT) from the German Heart Institute Berlin found right ventricular (RV) dysfunction develops in 20-50 percent of patients after left ventricular assist device (LVAD) implantation, leading to prolonged ICU stays and elevated mortality.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now